NCT00193583View on ClinicalTrials.gov

Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2005

Conditions

Cancer

Interventions

DRUG

Topotecan

DRUG

Carboplatin

Trial Locations (1)

37023

Tennessee Oncology, PLLC, Nashville

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER